✦ LIBER ✦

In Vitro and in Vivo Evaluation of Dihydropyrimidinone C-5 Amides as Potent and Selective α 1A Receptor Antagonists for the Treatment of Benign Prostatic Hyperplasia

✍ Scribed by Barrow, James C.; Nantermet, Philippe G.; Selnick, Harold G.; Glass, Kristen L.; Rittle, Kenneth E.; Gilbert, Kevin F.; Steele, Thomas G.; Homnick, Carl F.; Freidinger, Roger M.; Ransom, Rick W.; Kling, Paul; Reiss, Duane; Broten, Theodore P.; Schorn, Terry W.; Chang, Raymond S. L.; O'Malley, Stacey S.; Olah, Timothy V.; Ellis, Joan D.; Barrish, Andrea; Kassahun, Kelem; Leppert, Paula; Nagarathnam, Dhanapalan; Forray, Carlos

Book ID: 118145345
Publisher: American Chemical Society
Year: 2000
Tongue: English
Weight: 329 KB
Volume: 43
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm990612y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design and Synthesis of Novel α 1a Adren

Design and Synthesis of Novel α 1a Adrenoceptor-Selective Dihydropyridine Antagonists for the Treatment of Benign Prostatic Hyperplasia

✍ Nagarathnam, Dhanapalan; Wetzel, John M.; Miao, Shou Wu; Marzabadi, Mohammad R.; 📂 Article 📅 1998 🏛 American Chemical Society 🌐 English ⚖ 364 KB

SRD5A1 and SRD5A2 are Associated with Tr

SRD5A1 and SRD5A2 are Associated with Treatment for Benign Prostatic Hyperplasia with the Combination of 5α-Reductase Inhibitors and α-Adrenergic Receptor Antagonists

✍ Gu, Xin; Na, Rong; Huang, Tao; Wang, Li; Tao, Sha; Tian, Lu; Chen, Zhuo; Jiao, Y 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 210 KB

901 SRD5A1 and SRD5A2 genes are associat

901 SRD5A1 and SRD5A2 genes are associated with the treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic-receptor antagonist

✍ Gu, X.; Na, R.; Li, W.; Tao, S.; Tian, L.; Chen, Z.; Jiao, Y.; Kang, J.; Zheng, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Nonpeptide α v β 3 Antagonists. 8. In Vi

Nonpeptide α v β 3 Antagonists. 8. In Vitro and in Vivo Evaluation of a Potent α v β 3 Antagonist for the Prevention and Treatment of Osteoporosis

✍ Hutchinson, John H.; Halczenko, Wasyl; Brashear, Karen M.; Breslin, Michael J.; 📂 Article 📅 2003 🏛 American Chemical Society 🌐 English ⚖ 144 KB

DIHYDROTESTOSTERONE AND THE PROSTATE: TH

DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

✍ ANDRIOLE, G; BRUCHOVSKY, N; CHUNG, L; MATSUMOTO, A; RITTMASTER, R; ROEHRBORN, C; 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 191 KB

Design, Synthesis, In Vitro, and In Vivo

Design, Synthesis, In Vitro, and In Vivo Characterization of Phenylpiperazines and Pyridinylpiperazines as Potent and Selective Antagonists of the Melanocortin-4 Receptor

✍ Tran, Joe A.; Jiang, Wanlong; Tucci, Fabio C.; Fleck, Beth A.; Wen, Jenny; Sai, 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 438 KB